로딩 중…
지수 로딩 중…
Genmab A/S
GMAB· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
DK
DK$25.27-0.47%
2026-06-18
Price Chart
Genmab A/S+17.21%
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $15.51B |
| Revenue | $3.72B |
| Net Income | $964M |
| Total Assets | $12.84B |
| Net Assets | $5.83B |
| Value | |
| P/E | 16.10x |
| P/B | 2.66x |
| P/S | 4.17x |
| EV/EBITDA | 14.38x |
| FCF Yield | 7.41% |
| Profitability | |
| ROE | 16.52% |
| ROA | 7.50% |
| Op. Margin | 33.60% |
| Revenue Growth | -82.70% |
| Earnings Growth | -87.71% |
| Financial Health | |
| Debt Ratio | 120.16% |
| Total Debt | $5.43B |
| FCF | $1.15B |
| Cash | $1.71B |
| Current Ratio | 2.02x |
| Net Debt/EBITDA | 2.78x |
| Performance | |
| 1Y Return | 17.21% |
| 1M Return | -1.60% |
| From 52W High | -28.68% |
| 1Y MDD | -32.51% |
| Trading | |
| Volume | 1,808,154 shares |
| Trading Value | $46M |
| Per Share | |
| EPS | $4.47 |
| BPS | $9.47 |